当前位置: X-MOL 学术Lancet Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Cabozantinib plus atezolizumab in advanced hepatocellular carcinoma and the role of adjuvant antiviral therapy
The Lancet Oncology ( IF 51.1 ) Pub Date : 2022-07-04 , DOI: 10.1016/s1470-2045(22)00383-7
Fanpu Ji 1 , Mindie H Nguyen 2
Affiliation  

Abstract not available

中文翻译:

卡博替尼联合阿特珠单抗治疗晚期肝细胞癌及辅助抗病毒治疗的作用

摘要不可用
更新日期:2022-07-04
down
wechat
bug